These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31060226)

  • 21. Sterile Compounding Pharmacies: States That Do and Do Not Require Compliance With USP <797> Versus FDA 483s.
    Wilson M
    Ther Innov Regul Sci; 2016 May; 50(3):279-303. PubMed ID: 30227076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical Compounding in Portuguese Community Pharmacies: CHARACTERIZATION AND FUTURE PERSPECTIVES.
    Palmeira-de-Oliveira R; Macedo M; Machado RM; Pacheco AF; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Duarte P
    Int J Pharm Compd; 2016; 20(2):114-22. PubMed ID: 27323423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extemporaneous compounding in veterinary practice: a New Zealand perspective.
    Gargiulo DA; Chemal C; Joda L; Lee YJ; Pilkington M; Haywood A; Garg S
    N Z Vet J; 2013 Nov; 61(6):311-5. PubMed ID: 23544952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends of Extemporaneous Drug Prescription in Latvia in 2017.
    Kiselova O; Maurina B; Sidlovska V; Rogovska I
    Int J Pharm Compd; 2019; 23(3):245-249. PubMed ID: 31085793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability in compounding of oral liquids for pediatric patients: a patient safety concern.
    Rood JM; Engels MJ; Ciarkowski SL; Wagenknecht LD; Dickinson CJ; Stevenson JG
    J Am Pharm Assoc (2003); 2014; 54(4):383-9. PubMed ID: 25063260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E-prescribing errors identified in a compounding pharmacy: a quality-improvement project.
    Reed-Kane D; Kittell K; Adkins J; Flocks S; Nguyen T
    Int J Pharm Compd; 2014; 18(1):83-6. PubMed ID: 24881345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States.
    Lobb WB; Wilkin NE; Holmes ER
    Int J Pharm Compd; 2015; 19(6):514-20. PubMed ID: 26891565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How Compounding Pharmacies Fill Critical Gaps in Pediatric Drug Development Processes: Suggested Regulatory Changes to Meet Future Challenges.
    MacArthur RB; Ashworth LD; Zhan K; Parrish RH
    Children (Basel); 2022 Dec; 9(12):. PubMed ID: 36553327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of testosterone concentrations in compounded testosterone products.
    Grober ED; Garbens A; Božović A; Kulasingam V; Fanipour M; Diamandis EP
    J Sex Med; 2015 Jun; 12(6):1381-8. PubMed ID: 25963000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of pharmacogenetic testing in compounding pharmacy.
    Fichter B; Heintzelman T; Hurst S; Fitzsimmons D; Mailloux C
    Int J Pharm Compd; 2013; 17(6):452-7. PubMed ID: 24579294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compounding for animal patients: contemporary issues.
    Lust E
    J Am Pharm Assoc (2003); 2004; 44(3):375-84; quiz 384-6. PubMed ID: 15191248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, Scope and Quality of Extemporaneous Medications in Selected Healthcare Facilities and Implications for Pharmacy Practice.
    Allotey-Babington GL; Akwo Kretchy I; Atiapa Asiedu E; Kelly Amuakwa M; Akwele Seaneke O; Ankrah D; Kwadwo Somuah A; Dei Owusu-Nyamekye A; Owusu-Ansah S; Kwame Effah P; Debrah J; Acheampomaa Nai E; Owusu E; Lamptey W; Gyekye IJA; Nettey H
    Innov Pharm; 2024; 15(1):. PubMed ID: 38779112
    [No Abstract]   [Full Text] [Related]  

  • 33. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction to hospital compounding.
    McElhiney LF
    Int J Pharm Compd; 2006; 10(4):245-50. PubMed ID: 23974255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension.
    McElhiney LF
    Int J Pharm Compd; 2021; 25(1):24-28. PubMed ID: 33503007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Extemporaneous Prescriptions Prescribed by Dermatovenerologists in Latvia and Comparison with Standardized Compounded Preparation Monographs of Germany and USA.
    Kiseļova O; Mauriņa B; Šidlovska V
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compounding & dispensing errors before and after implementing barcode technology in a nuclear pharmacy.
    Galbraith W; Shadid J
    Int J Pharm Compd; 2012; 16(3):253-6. PubMed ID: 23050303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey.
    Kairuz T; Chhim S; Hasan F; Kumar K; Lal A; Patel R; Singh R; Dogra M; Garg S
    N Z Med J; 2007 Mar; 120(1251):U2466. PubMed ID: 17384694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Communicating doses of pediatric liquid medicines to parents/caregivers: a comparison of written dosing directions on prescriptions with labels applied by dispensed pharmacy.
    Shah R; Blustein L; Kuffner E; Davis L
    J Pediatr; 2014 Mar; 164(3):596-601.e1. PubMed ID: 24367987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of medicines for children - a hierarchy of classification.
    Ernest TB; Craig J; Nunn A; Salunke S; Tuleu C; Breitkreutz J; Alex R; Hempenstall J
    Int J Pharm; 2012 Oct; 435(2):124-30. PubMed ID: 22677416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.